Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,442.00    -34.00 (-2.30%)
Bid:
1,440.00
Ask:
1,446.00
Spread: 6.00 (0.417%)
Market Cap: £493.70m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Significant Contract Win

23 Mar 2017 07:00

RNS Number : 2611A
Craneware plc
23 March 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Win

 

23 March 2017 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce a significant new contract with a large hospital operator in the US.

 

This win, with an existing customer, adds further Value Cycle solutions and related services to a seven year contract originally announced in April 2014. The contract is expected to deliver a further $3.7m of revenue over this new seven year term as the hospital network rolls out these additional solutions across its facilities and $1.5m of additional revenue as the contract for the currently implemented solutions is extended to run co-terminus to this amendment.

 

In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from this contract will be recognised over future periods, adding to the Group's long term visibility of revenue under contract.

 

Keith Neilson, CEO of Craneware plc, commented, "The strategic importance of Craneware's Value Cycle solutions allow us to add new customers and deepen our relationship with our existing customers as both groups address the challenges resulting from the continued evolution to the new value based re-imbursement environment. The extension of the solution set provided to this customer and increasing the duration of the original contract underlines the value our solutions bring to our customers. We have a very positive relationship with our customers, demonstrating sustainable value; we now look forward to this extension of our working relationship with this customer to over a decade."

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn McConnachie

Josh Royston

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGMGZFMZVGNZZ
Date   Source Headline
2nd Jul 20127:00 amRNSTrading Update
15th Jun 201210:57 amRNSTotal Voting Rights
31st May 201212:32 pmRNSHolding(s) in Company
29th May 20121:03 pmRNSHolding(s) in Company
28th May 20124:14 pmRNSHolding(s) in Company
28th May 20124:11 pmRNSHolding(s) in Company
8th May 20125:41 pmRNSHolding(s) in Company
27th Apr 20125:09 pmRNSHolding(s) in Company
26th Apr 20124:17 pmRNSHolding(s) in Company
26th Apr 20123:46 pmRNSHolding(s) in Company
23rd Apr 20126:14 pmRNSTotal Voting Rights
23rd Apr 20126:13 pmRNSBlocklisting Interim Review
16th Apr 201212:57 pmRNSHolding(s) in Company
30th Mar 201212:36 pmRNSHolding(s) in Company
29th Mar 20125:02 pmRNSHolding(s) in Company
28th Mar 20123:39 pmRNSHolding(s) in Company
20th Mar 201212:12 pmRNSHolding(s) in Company
12th Mar 20125:51 pmRNSDividend Currency Election
8th Mar 201212:57 pmRNSHolding(s) in Company
5th Mar 201212:17 pmRNSTotal Voting Rights
2nd Mar 20123:24 pmRNSHolding(s) in Company
29th Feb 20125:43 pmRNSHolding(s) in Company
28th Feb 20124:29 pmRNSDirector/PDMR Shareholding
28th Feb 20127:00 amRNSChannel Partner Contract Win
28th Feb 20127:00 amRNSHalf Yearly Report
17th Feb 20123:29 pmRNSHolding(s) in Company
1st Feb 20127:00 amRNSNotice of Results
31st Jan 201210:00 amRNSHolding(s) in Company
16th Jan 20123:40 pmRNSHolding(s) in Company
12th Jan 20126:28 pmRNSHolding(s) in Company
11th Jan 20124:55 pmRNSHolding(s) in Company
10th Jan 20127:00 amRNSTrading Update
11th Nov 20111:14 pmRNSDividend Currency Election
10th Nov 201110:36 amRNSResult of AGM
10th Nov 20117:00 amRNSAGM Statement
1st Nov 20115:39 pmRNSTotal Voting Rights
1st Nov 201112:29 pmRNSBlocklisting Interim Review
25th Oct 20111:42 pmRNSDirector/PDMR Shareholding
18th Oct 20112:26 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20114:43 pmRNSTotal Voting Rights
26th Sep 20117:00 amRNSGrant of Options
31st Aug 201111:53 amRNSDirector/PDMR Shareholding
30th Aug 20117:00 amRNSFinal Results
22nd Aug 20115:02 pmRNSHolding(s) in Company
22nd Aug 20114:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20114:35 pmRNSPrice Monitoring Extension
19th Aug 20114:40 pmRNSSecond Price Monitoring Extn
19th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20113:49 pmRNSHolding(s) in Company
19th Jul 20117:00 amRNSTrading Update and Contract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.